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Abstract 28
Circulating vitamin C and carotenoids are used as biomarkers of fruit and vegetable intake in 29
research, but their comparative validity has never been meta-analysed. PubMed, EMBASE, 30
CENTRAL, CINAHL and Web of Science were systematically searched to December 2013 for 31
randomised trials of different amounts of fruit and vegetable provision on changes in blood 32
concentrations of carotenoids or vitamin C. Reporting followed PRISMA guidelines. Evidence 33
quality was assessed using the GRADE system. Random effects meta-analysis combined 34
estimates and meta-regression tested for sub-group differences. Nineteen fruit and vegetable 35
trials (n=1382) measured at least one biomarker, of which nine (n=667) included five common 36
carotenoids and vitamin C. Evidence quality was low and between-trial heterogeneity (I2) 37
ranged from 74% for vitamin C to 94% for -carotene. Groups provided with more fruit and 38
vegetables had increased blood concentrations of vitamin C, -carotene, -carotene, -39
cryptoxanthin, and lutein but not lycopene. However, no clear dose-response effect was 40
observed. Vitamin C showed the largest between group difference in standardised mean 41
change from pre- to post-intervention (0.94, 95% CI 0.66, 1.22), followed by lutein (0.70, 95% 42
CI 0.37, 1.03) and -carotene (0.63, 95% CI 0.25, 1.01) but all confidence intervals were 43
overlapping suggesting no biomarker responded more than others. Therefore, until further 44
evidence identifies a particular biomarker to be superior, group-level compliance to fruit and 45
vegetable interventions can be indicated equally well by vitamin C or a range of carotenoids. 46
High heterogeneity and a lack of dose-response suggest that individual-level biomarker 47
responses to fruit and vegetables are highly variable. 48
Word count: 25049
3Introduction50
Higher fruit and vegetable intake has been associated with reduced risk of cardiovascular 51
disease (CVD), all-cause mortality and specific types of cancer (1; 2; 3; 4). The World Health 52
Organisation (WHO) recommend 400g of fruit or vegetables per day (5), equating to five 80g 53
portions, and encourages the evaluation of interventions to increase intake of fruits and 54
vegetables (5). Adherence to advice in dietary interventions is frequently assessed by self-55
report tools (6), which have known limitations (7; 8; 9). Social approval bias specifically occurs in 56
fruit and vegetable interventions resulting in overestimated self-reported intakes (9). Objective 57
measures of fruit and vegetable intake are therefore essential to improve confidence in 58
research findings. 59
60
Blood-based biomarkers, resulting from the metabolism of fruits and vegetables in the body, 61
have been proposed as objective indicators of fruit and vegetable intake (10). Biomarkers 62
correlate weakly with fruit and vegetable intake assessed by a range of self-report tools (11; 12). 63
For example, a meta-analysis estimated the correlation between dietary and plasma vitamin 64
C to be just r=0.3 (13). However, comparing biomarkers with self-reported intakes to establish 65
validity is flawed because true intakes are poorly represented by self-report tools. Dietary 66
randomised controlled trials (RCTs), with direct observation or provision of different amounts 67
of fruit and vegetables to different groups, provide a more robust way to validate biomarkers 68
of changes in dietary intake. Randomisation may rule out confounding from other lifestyle 69
factors and the direct observation or provision of fruit and vegetables may allow true intakes 70
to be more accurately estimated compared with self-reported intakes from groups randomised 71
to different dietary advice (potential for differential priming for social desirability bias). 72
73
In a systematic review of RCTs published up to April 2009 (14) the most commonly measured 74
and consistently responsive biomarkers for fruits and vegetables were carotenoids and 75
vitamin C. However, there was no meta-analysis to quantify the responsiveness or examine 76
the consistency of response of carotenoids and vitamin C. Furthermore, there was no 77
comparative analysis of different biomarkers measured within the same set of studies, which 78
would allow the relative validity of different biomarkers to be established. The current 79
systematic review updates the existing review with a specific focus on the effect of changes in 80
4fruit and vegetable intake on blood concentrations of vitamin C and carotenoids in RCTs with 81
food intake directly observed or provided to participants. To provide a direct comparison of 82
different biomarkers, our primary analysis focussed on those trials in which a common set of 83
vitamin C and five carotenoids were measured.84
85
Methods86
The review was reported according to items in the PRISMA statement (Supplementary table 87
1).88
89
Trial identification90
A previous systematic review provided studies prior to 2009 in the current review (14). Updated 91
searches were conducted (by LJ) from April 2009 (last search date of previous systematic 92
review (14)) to December 2013 in PubMed, EMBASE, CENTRAL, CINAHL and Web of 93
Science using terms related to fruits and vegetables, dietary intervention studies and 94
biomarkers (see online supplementary information for detailed search strategy). Any relevant 95
systematic reviews were obtained and their reference lists were examined for additional 96
references. Citations were screened by one reviewer (MP or LJ) and hard copies of relevant 97
articles obtained. These were screened by one reviewer (MP) and checked for inclusion by a 98
second reviewer (LJ). 99
100
Inclusion and exclusion criteria101
Randomised controlled trials of different amounts of fruit and vegetable intake (where some 102
food intake was observed or provided) with outcomes of plasma or serum vitamin C or 103
carotenoids were included in the review. Interventions of any duration were considered for 104
inclusion. Trials altering other aspects of diet, in addition to fruit and vegetable intake, for 105
example low-fat diets, were excluded to avoid the possibility that changes in blood-based 106
biomarkers were a result of dietary changes other than fruit and vegetables. Intervention 107
studies of a single fruit or vegetable were excluded. Findings from these types of interventions 108
may underestimate the utility of biomarkers for measures of general fruit and vegetable intake 109
as any single food contains a more limited range of nutrients. Trials where fruit and vegetable 110
5intake was encouraged through dietary advice were excluded since adherence to the advice 111
is harder to estimate. Trials in healthy or unhealthy populations were included, including 112
populations with high CVD risk factors or impaired glucose metabolism. However, trials in 113
populations with abnormalities in micronutrient metabolism or vitamin deficient populations 114
were excluded. Trials were included if they reported biomarker measurements, either as 115
changes from baseline or as baseline and post-intervention values, and if information was 116
available on the amount of fruit and vegetables consumed in each intervention group. 117
118
Data extraction119
Data on trial and population characteristics and outcomes were extracted into an Excel form 120
that was piloted on a sample of trials before use (by MP, MS, LJ, CM). Data extracted on trial 121
characteristics included the type of trial (parallel or crossover), duration of intervention, 122
information on the duration of pre- and within-intervention washout periods, the amount and 123
types of fruits and vegetables consumed and the mode of administration (some meals eaten 124
under supervision vs. all meals at home), smoking status, fasting status at the time of 125
biomarker measurement, the use of dietary supplements, inclusion and exclusion criteria and 126
funding sources. Population characteristics included the sample size, country and type of 127
sample, e.g. clinical or general population, and participant demographics, including age, sex 128
and ethnicity were also extracted. Where available, data on baseline, post-treatment and 129
change in biomarker concentrations were extracted for each trial arm. Where data on the 130
amount of fruit and vegetables provided or biomarker levels was incomplete or lacked 131
estimates of precision, authors were contacted. For four trials (15; 16; 17; 18), data were supplied 132
by authors and included in the review.133
  134
Quality assessment135
A risk of bias (ROB) assessment was conducted (by MP) using the Cochrane risk of bias tool 136
(19). Randomisation, allocation concealment, participant and assessor blinding, missing data, 137
and selective outcome reporting were assessed. Other items hypothesised to potentially 138
introduce risk of bias were also added: the exclusion of participants taking supplements or 139
smoking, participant fasting at the time of blood sampling, diet adherence monitoring and 140
sufficient intervention wash-out periods (for cross-over trials) (≥4 weeks). The ROB for each 141
6trial was considered on the basis of whether any of the items, individually or in combination 142
with others, were likely to have introduced bias and trials were assigned as having no, 143
possible or high ROB. The overall quality of the evidence for each outcome was assessed 144
with the GRADE system (20) that considers 1) the ROB across trials contributing to that 145
outcome, 2) heterogeneity in the meta-analysis, 3) directness, or the generalisability of the 146
population in the trial, 4) precision of the effect size and 5) risk of publication bias.147
148
Data analysis149
Standardised mean change (SMC) and standard deviation (SD) of biomarker concentrations 150
from pre- to post-intervention were computed using the baseline SD within each trial arm, 151
owing to variation in the units reported across studies (mol/L; mg/dL; mol/mol of 152
cholesterol; mol/mol of lipid). Effect sizes (standardised mean difference (SMD)) were the 153
difference of the SMC of biomarkers between arms with higher vs. lowest fruit and vegetable 154
intake. The standard error of the SMD was computed from the variance of the SMC and the 155
sample size in each arm. For trials with more than two arms, the arm with the lowest fruit and 156
vegetable intake was compared against all other arms. To account for the use of the lowest 157
intake arm in multiple comparisons, the sample size of that arm was divided by the number of 158
comparison groups within that study (21). Fruit and vegetable intake was described in terms of 159
number of portions using standard UK portion sizes i.e. one portion equates to 80g of fruit or 160
vegetables (22). 161
162
Mean differences in changes in biomarker between groups allocated different doses of fruits 163
and vegetables across the whole study in crossover designs were assumed to be the same 164
as mean differences between groups in parallel study designs. Where average biomarker 165
concentrations pre- and post-intervention were described using medians or geometric means, 166
these were assumed to approximate the mean; and 95% confidence intervals or interquartile 167
ranges were transformed to approximate the SD assuming a normal distribution. Where data 168
on change was not available, pre- and post-intervention mean (SD) concentrations were 169
extracted and mean change was computed by subtracting pre-intervention mean from post-170
intervention mean in each arm. The SD of the standardised mean change was computed 171
using standard equations (21) based on the SD at baseline and SD at follow-up within each 172
7arm and biomarker-specific correlations (r) based on published associations between 173
baseline and follow-up concentrations of biomarkers (23; 24). Post-hoc sensitivity analyses were 174
performed to check the influence of all assumptions on the results and the pattern of findings 175
was unaltered.176
177
For each biomarker, SMD (standard error (SE)) was pooled across all trials using random 178
effects meta-analysis with inverse variance weights and heterogeneity was estimated using I2 179
(25). Heterogeneity of was considered low or high if I2 was <25% or >75% respectively. For the 180
primary analysis, data were combined for each biomarker for trials that included vitamin C, 181
and a common set of 5 carotenoids (-carotene, -carotene, -cryptoxanthin, lutein and 182
lycopene). Sub-group analyses planned a-priori were conducted for each biomarker using 183
meta-regression to investigate potential dose-response effect (difference in fruit and 184
vegetables intake between arms in each trial in g/day) and sources of heterogeneity, including 185
differences by intervention duration (0-3 weeks vs. 4+ weeks, categories created based on 186
data available); intervention compliance (meals observed vs. eaten at home); trial design 187
(crossover vs. parallel); health status (healthy vs. unhealthy); location (Europe vs. US vs. 188
Asia-Pacific); type of food provided (fruit and vegetables vs. vegetables only, categories 189
created based on data available); baseline fruit and vegetable intake (<1 portion vs. 2-3 190
portions vs. 4-5 portions, categories created based on data available); fasting status (fasted 191
vs. not); blood sample fraction (plasma vs. serum); risk of bias (low vs. possible vs. high); and 192
sex (mixed vs. male vs. female). To check for a possible ceiling effect among participants with 193
elevated biomarker concentrations, we also performed subgroup analyses by baseline 194
biomarker concentrations (low vs. high based on median split, categories created based on 195
data available). For sub-group analyses, all trials with that biomarker measured were used, 196
regardless of the simultaneous measurement of other biomarkers. As substantial (I2>75%) 197
between-trial heterogeneity was observed, a post-hoc sensitivity analysis was conducted to 198
examine the effect of excluding trials with outlying results (more than 2 standard deviations 199
from the SMD) from the analysis. Statistical evidence of association was considered important 200
at p<0.05. Data were analysed in Stata, version 12 (StataCorp, College Station, Texas).201
202
Results203
8204
Trial selection205
Of 3,759 unique records, 144 full text articles were assessed for inclusion and nineteen trials 206
were included in the review (Figure 1). Nineteen trials were identified in this review, 10 of 207
which were also included in the previous systematic review (14). Out of the 19 trials, nine (23; 26; 208
27; 28; 29; 30; 31; 32; 33) assessed a common set of six biomarkers including five carotenoids and209
vitamin C (Supplementary table 2) and were included in the comparative (primary) analysis. 210
Of the papers rejected on full text screening, the majority were excluded on the basis of the 211
intervention, often because trials involved only dietary advice, or because the intervention 212
targeted a single fruit or vegetable only. Other common reasons for exclusion were wrong 213
study design (not RCT with food provision) or wrong outcomes (no biomarker concentrations). 214
215
Trial characteristics216
Trial characteristics for all the included trials are shown in Table 1. Twelve trials were 217
conducted in healthy populations (15; 17; 23; 27; 28; 31; 32; 34; 35; 36; 37; 38). Two trials were conducted in 218
populations with increased CVD risk (29; 33) and single trials were in populations with obesity 219
(39), overweight (16), hypertension (30), elevated blood pressure (18) or chronic obstructive 220
pulmonary disease (COPD) (26). Within trial differences in intake of fruit and vegetables 221
ranged from 2 to 13 portions /day. The sample sizes ranged from 20 to 246 participants 222
(median 64). For the nine trials included in the comparative analysis, the difference in amount 223
of fruit and vegetables between arms ranged from 2-7 portions/day. 224
225
Quality of the evidence226
In the GRADE assessment of the quality of each outcome in the meta-analysis, no outcomes 227
were downgraded for imprecision or indirectness. However, most trials were considered to 228
have some ROB (Figure 2). Trials did not state that there was allocation concealment and 229
patient blinding was not possible. In a number of studies, there were inadequate pre- and 230
within-intervention washout periods and uncertainties around the true ingested amounts of 231
fruits and vegetables (less adherence monitoring) (Figure 2). In the absence of washout 232
periods, there was considered to be risk of pre-intervention or cross-treatment contamination. 233
9In trials where consumption of fruit and vegetables was not directly observed, there was 234
considered to be a likely over-estimation of the true ingested amount. A concern in some trials 235
was the inclusion of participants using nutritional supplements, a lack of fasting at the time of 236
outcome measurement and the inclusion of patients who smoked. Funnel plots suggested the 237
possibility of publication bias and heterogeneity for α-carotene, β-carotene, β-cryptoxanthin, 238
and vitamin C (based on the occurrence of studies outside of the triangular region indicating 239
where 95% of studies should be in the absence of bias or heterogeneity) (Figure 3). All 240
outcomes were downgraded for inconsistency as there was substantial heterogeneity in the 241
meta-analysis. Overall, evidence for all outcomes was graded as low quality. 242
243
Findings244
The primary focus for this review was trials including measures of all six biomarkers so that 245
their comparative utility could be assessed (Figure 4). All biomarker concentrations, except 246
lycopene, increased more from pre- to post-intervention in the arm providing higher amounts 247
of fruit and vegetables compared to the arm providing lower amounts; α-carotene (SMD 0.63, 248
95% CI 0.25, 1.01), β-carotene (SMD 0.27, 95%CI 0.08, 0.45), β-cryptoxanthin (SMD 0.52, 249
95% CI 0.30, 0.74), lutein (SMD 0.70, 95% CI 0.37, 1.03) and vitamin C (SMD 0.94, 95% CI 250
0.66, 1.22). For lycopene there was no evidence of greater change in plasma concentrations 251
(SMD -0.02, 95% CI -0.27, 0.23) in response to higher fruit and vegetable intake. There was 252
substantial between-trial heterogeneity in the pooled effects for all biomarkers (I2=74-94%). In 253
the sensitivity analyses, where trials with extreme outlying results were excluded, seven out of 254
nine trials remained in the analysis (Supplementary figure 1). Effect sizes were smaller for 255
all biomarkers but a similar pattern was observed, where there were significant effects for α-256
carotene, β-carotene, β-cryptoxanthin, lutein and vitamin C but again no evidence of a 257
difference for lycopene. Heterogeneity was reduced for β-crytoxanthin, lutein, lycopene and 258
vitamin C (I2=46-66%), but remained significant (Supplementary figure 1). Further sensitivity 259
analyses utilising information for each biomarker from all available studies (indirect 260
comparisons) (Supplementary figure 2) and excluding non-normally distributed data 261
(Supplementary figure 3) did not alter the pattern of results.262
263
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Individual meta-analyses for each biomarker including up to nineteen trials are shown in 264
Supplementary figures 4-9. For these indirect comparisons, the same pattern was observed 265
as for direct comparisons, with statistically significant effects for all biomarkers except 266
lycopene. For these indirect analyses we were able to additionally estimate effects for 267
zeaxanthin (Supplementary figure 10) and total carotenoids (Supplementary figure 11), 268
which were available in a smaller number of studies. Both showed increases in response to 269
high compared with low amounts of fruits and vegetables but were also highly heterogeneous 270
(I2= 84 and 93% respectively).271
272
All trials providing data on at least one biomarker were included in the investigation of dose 273
response and sub-group analyses. In meta-regressions of within-trial difference in amount of 274
fruit and vegetables (grams/day) against SMD of biomarker level, there was no evidence of a 275
dose-response effect (all p>0.05). When the difference in the amount of fruit and vegetables 276
consumed in each arm was categorised into portions (2-3 vs. 4-5 vs. >5 portions), a trend 277
towards higher biomarker concentrations among trials where the group difference in fruit and 278
vegetable intake was greater emerged but was only statistically significant for -carotene 279
(p=0.01, Figure 5). 280
281
Other notable findings from subgroup analyses included stronger effects for α-carotene, β-282
carotene, lutein and vitamin C in trials where participants ate meals under supervision 283
compared to trials where all food was eaten at home, accounting for 12-38% of the 284
heterogeneity (Supplementary figure 12). Shorter interventions (0-3 weeks) were associated 285
with significantly greater effect sizes compared to longer (≥4 weeks) interventions for α- and 286
β-carotene. There were non-significant trends for a similar effect for lutein, lycopene and 287
vitamin C, accounting for between 6-20% of the heterogeneity (Supplementary figure 13). 288
Trials in healthy populations tended to show greater effect sizes compared with trials in 289
unhealthy populations (Supplementary figure 14) and this was significant for α- and β-290
carotene (accounting for 17-18% of the heterogeneity). In the sensitivity analysis, excluding 291
outlying results, there was still a significant effect of disease status for α- and β-carotene. In 292
the sensitivity meta regressions including intervention delivery, duration and participant health 293
status all together associations were unaltered (data not shown).294
11
295
Trials conducted in the USA had significantly greater effect sizes compared with those 296
conducted in Europe for α- and β-carotene (Supplementary figure 15), which was robust to 297
adjustment for other factors for -carotene. The effect size was greater for crossover 298
compared with parallel trials for β-carotene and lutein (Supplementary figure 16), which was 299
attenuated after adjustment for other factors (data not shown). For α-carotene and lutein there 300
was a greater effect size for trials where vegetables alone were given compared to trials 301
where both fruit and vegetables were given (Supplementary figure 17), but these findings 302
were not robust to adjustment (data not shown). There was no evidence of differences across 303
sub-groups defined by baseline fruit and vegetable intake, fasting status, blood fraction 304
(plasma or serum) or risk of bias (data not shown). 305
306
Discussion307
In this systematic review we identified nine additional RCTs compared with a previous 308
systematic review (14), providing the largest evidence base to date for meta-analysis of the 309
validity of carotenoids and vitamin C based on highly controlled validation studies.  While 310
previous reviews have not been able to comment on the comparative validity of different 311
biomarkers, our results highlight that vitamin C and 4 common carotenoids may all be equally 312
useful as a biomarker for objectively measuring general fruit and vegetable intake. 313
314
Similar to a previous systematic review(14), vitamin C and carotenoids were identified as 315
commonly used biomarkers for fruits and vegetables. In the previous systematic review these 316
biomarkers are qualitatively described as consistently responding to increased fruit and 317
vegetable intakes. Our meta-analysis provides quantitative evidence to support that vitamin 318
C, α- and β-carotene, β-cryptoxanthin and lutein all increase in response to a high fruit and 319
vegetable intake but high heterogeneity estimates suggest a lack of consistency in the size of 320
the response observed between studies.321
322
Meta-regression of fruit and vegetable dose on changes in biomarker concentration showed 323
no evidence of a dose-response relationship for any biomarkers. While pooled biomarker 324
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responses in sub-groups defined by increasing fruit and vegetable dose appeared to be 325
incrementally greater, the differences were not statistically significant. The absence of dose-326
response in our review may be explained by ceiling effects, where plasma biomarker 327
concentrations reach a peak and do not increase further in response to higher fruit and 328
vegetable intakes because excess levels are stored in body tissue or excreted. In the 329
included trials, the difference in fruit and vegetable dose was typically 5-6 portions per day, 330
equivalent in one trial to 194 mg of vitamin C and 4 mg/day of -carotene (29). Vitamin C 331
saturation can occur at intakes as low as 30-60 mg/day (40) whereas, for β-carotene, doses up 332
to 45mg/day are within a physiologically responsive range (41). Ceiling effects may affect 333
vitamin C but may have less impact on the plasma response of β-carotene and other 334
carotenoids that have a wider physiologically responsive range. However, our sub-group 335
analyses found no evidence of differences in the pooled effects by baseline fruit and 336
vegetable intake or baseline biomarker, even for vitamin C concentrations, indicating that 337
ceiling effects were unlikely to be affecting dose-responses at the tested levels of intake.338
339
Alternatively, trial integrity may have had a role masking a dose-response curve. Adherence 340
to the intervention might be anticipated to be lower for people in groups allocated to higher 341
doses of fruits and vegetables e.g. it’s harder to comply with eating 8-9 portions per day than 342
4 portions per day and differential compliance by dose may explain the lack of observed dose 343
response. Shorter (0-3 weeks) compared with longer (≥4 weeks) interventions had larger 344
effects, which may be explained by reduced compliance in longer trials owing to intervention 345
fatigue. The half-life of some biomarkers is relatively short, with plasma biomarker 346
concentrations reducing to baseline over 2-3 weeks (41). However, in this review, shorter trials 347
were also more likely to have supervised meals. Five of eight studies of 0-3 weeks duration 348
(63%) vs. three of eleven (27%) trials of 4+ weeks duration involved supervised meals. We 349
found that trials with supervised meals had larger pooled effects compared with trials without 350
supervision, likely reflecting better intervention adherence and more accurately representing 351
the intervention-biomarker relationship. 352
353
The presence of supervised feeding in trials explained only between 12% (for -carotene) and 354
38% (for lutein) of the between-trial heterogeneity, suggesting that other individual and trial-355
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level factors also influence the observed biomarker-fruit and vegetable intake relationship. 356
Individual-level factors, such as age, sex and BMI, the efficiency of absorption and excretion, 357
differences in smoking, alcohol, dietary and exercise habits and variation in the presence of 358
underlying disease/metabolic disorders, are suggested influences on the relationship between 359
fruit and vegetable intake and biomarker status (10; 41; 42). Several of these moderating factors 360
were explored in sub-group analyses. Health status was identified as a source of 361
heterogeneity; trials that recruited participants who were overweight, hypertensive or at high 362
risk of CVD had lower pooled effect sizes than trials of healthy participants. Factors related to 363
CVD, such as chronic low grade inflammation, can affect the absorption, metabolism and 364
storage of biomarkers in the body (10), which may explain the reduced effect of interventions in 365
populations with disease/metabolic disturbances. One key trial-level difference not captured 366
fully in our sub-group analyses was the variation in the types of fruits and vegetables provided 367
to participants. Diets with fruits and vegetables that were richer in vitamin C and carotenoids 368
may have shown a stronger relationship with biomarker levels. However, although the type of 369
fruits and vegetables provided was reported in 11 out of 19 studies, the amount of each type 370
was not consistently described. Without information on both the type and amount of specific 371
fruits and vegetables it was not possible to accurately estimate the vitamin C or carotenoid 372
content of diets. We included any studies changing more than one type of fruit or vegetable in 373
order to represent 'general' changes in intake but it is possible that the micronutrient 374
composition of the fruits and vegetables provided could further explain some of the 375
heterogeneity in biomarker responses between studies.376
377
According to the GRADE assessment, the evidence was low quality therefore “Further 378
research is very likely to have an important impact on our confidence in the estimate of effect 379
and any estimate of effect is very uncertain” (20). The interpretation of results in this review is 380
limited by the high level of heterogeneity observed between trials, which could not be fully 381
explained in sub-group analyses. In assessing fruit and vegetable intake not only is there 382
likely to be large between-population variation, but there is also likely to be large variation in 383
the biomarker response of individuals (41; 42; 43). The evidence from this meta-analysis does not 384
provide support for the use of biomarkers to estimate absolute levels of fruit and vegetable 385
intake because of a lack of dose-response effect. It also does not provide support for 386
estimating changes in fruit and vegetable intake in individuals because only group-level 387
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differences were quantified in the trials. Further studies of the determinants of within and 388
between individual variation in vitamin C and carotenoid levels in large-scale studies with 389
biomarkers measured at multiple time-points will help to understand the relative importance of 390
changes in fruit and vegetable consumption for changes in biomarker concentrations.391
392
Strengths of the present systematic review include the identification of nine trials additional to 393
the previous review, thus allowing an in-depth exploration of between-trial heterogeneity and 394
a comparative analysis restricted to nine trials with a common set of biomarkers measured 395
(five were newly identified by our update to the review). However, some uncertainty remains 396
regarding the comparative utility of different biomarkers. Although vitamin C had the greatest 397
response, it was not significantly greater from the response of other biomarkers. Therefore, 398
no particular biomarker can be recommended above the others on the basis of our results 399
thus selection may be based on study needs. The review included only randomised controlled 400
trials that directly observed or provided fruit and vegetables. This restriction reduced the 401
number of included trials compared to previous reviews (14), but is considered a strength 402
because observed effects are less confounded by potential exposure misclassification related 403
to low compliance or other dietary changes associated with dietary interventions. 404
405
The present systematic review and meta-analysis confirm that vitamin C and carotenoids 406
(except lycopene) are responsive to changes in general fruit and vegetable intake at a group 407
level. However, the evidence was of low quality, there was no clear evidence of dose-408
response or that any single biomarker was more responsive. Further work is required to 409
understand the determinants of biomarker variation among individuals.410
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Table 1: Characteristics of 19 randomised controlled trials of fruit and vegetable intake on biomarker concentrations541
Fruit and vegetable 
intake (Portions/day)
Author Year Population Location Design N
Mean 
age 
(yrs)
Method Intervention
Interventi
on 
duration 
(wks)
Run-
in 
(wks) Baseline Treatment
Blood 
fraction
Fasted 
state
Smokers 
excluded?
GP1 1.4 GP1 1.9
Baldrick (26) 2012 COPD UK Parallel 81 62
Provided F&V, 
delivered to 
homes
F&V 13 0
GP2 1.5 GP2 6.1
Plasma
Non-
fasting
No
GP1 3.6 GP1 3.6
GP2 3.6 GP2 6.7Berry (18) 2010
Elevated 
blood 
pressure
UK
Cross 
over
57 45
Provided F&V, 
delivered to 
homes
F&V 6 3
GP3 3.6 GP3 8.0
Plasma Fasted Yes
GP1 NR GP1 3.8
Brevik (34) 2004
Healthy -
students
Norway
Cross 
over
39 23
Foods supplied 
and eaten under 
supervision
F&V 2 1
GP2 NR GP2 9.4
Plasma Fasted Yes
GP1 2.8 GP1 2.5
GP2 3.3 GP2 5.8Briviba (27) 2008
Healthy -
general
Germany Parallel 63 NR
Foods supplied 
and lunch eaten 
under 
supervision
F&V 3 1
GP3 3.1 GP3 9.8
Plasma NR Yes
GP1 2.0 GP1 1.3
Broekmans 
(28) 2000
Healthy -
Low F&V
The 
Netherlands
Parallel 48 49
Foods supplied 
and dinner eaten 
under 
supervision
F&V 4 NR
GP2 2.0 GP2 6.3
Plasma Fasted No
Chong (29) 2013 Increased UK Parallel 221 51 Provided F&V, F&V 18 2 GP1 3.9 GP1 4.5 Plasma Fasted No
22
GP2 3.8 GP2 7.6
CVD risk delivered to 
homes
GP3 3.4 GP3 8.1
GP1 NR GP1 1.6
GP2 NR GP2 3.6Crane (16) 2011
Overweight 
(BMI 25-45), 
post-
menopausal 
women
USA
Cross 
over
50 59
Provided F&V, 
delivered to 
homes
Veg only 3 4
GP3 NR GP3 7.7
Plasma Fasted No
GP1 3.3 GP1 3.3
Dragsted 
(17) 2004
Healthy –
general
Denmark Parallel 48 26
Foods supplied 
and lunch eaten 
under 
supervision
F&V 4 0.4
GP2 4.1 GP2 7.5
Plasma Fasted Yes
GP1 NR GP1 0.0
Gill (23) 2004
Healthy 
volunteers
UK Parallel 20 26
Foods provided 
(NR where 
consumed)
Veg only 2 1
GP2 NR GP2 1.4
Plasma Fasted NR
GP1 NR GP1 1.2
Howe (39) 2009 Obese USA Parallel 37 33
Food provided at 
breakfast and 
lunch
F&V 13 NR
GP2 NR GP2 2.5
Serum Fasted No
GP1 NR GP1 0.0
GP2 NR GP2 6.8Martini 
(38) 1995 Healthy USA
Crosso
ver
23 26
Ate on site or 
picked up to eat 
at home
Veg only 1 0.7
GP3 NR GP3 8.6
Plasma Fasted Yes
GP1 0.9 GP1 1.1
GP2 1.1 GP2 3.2McCall (30) 2009
Hypertensio
n
UK Parallel 147 52
Food delivered to 
home, weekly 
phone calls
F&V 8 4
GP3 1.1 GP3 5.6
Serum Fasted No
23
GP1 3.3 GP1 0.0
Moller (35) 2003
Healthy -
general
Denmark Parallel 48 26
Foods supplied 
and lunch eaten 
under 
supervision
F&V 4 0.6
GP2 4.2 GP2 7.5
Plasma Fasted Yes
GP1 1.4 GP1 1.8
Neville (31) 2013
Healthy, 
Older adults
UK Parallel 83 71
Advice and home 
deliveries of F&V
F&V 16 0
GP2 1.4 GP2 6.0
Plasma Fasted No
GP1 NR GP1 2.9
Rantala (15) 2002
Healthy 
women
Finland
Crosso
ver
37 43
Ate on site or 
picked up to eat 
at home
F&V 5 2
GP2 NR GP2 8.3
Plasma Fasted Yes
GP1 4.5 GP1 5.4
Thompson 
(36) 2005
Healthy -
women's 
health 
interest 
group
USA Parallel 246 48
Cookbook with 
daily menus and 
recipes and one-
third of meals 
supplied
F&V 4 2
GP2 4.5 GP2 13.8
Plasma NR Yes
GP1 NR GP1 5.4Thompson 
(37)
2005
b
Healthy -
unclear 
source
USA Parallel 64 49 Foods prescribed F&V 2 0
GP2 NR GP2 18.2
Plasma
Non-
fasting
NR
GP1 NR GP1 1.6
Van het Hof 
(32) 1999
Healthy -
general
The 
Netherlands
Parallel 55 22
Foods supplied 
(90% of energy 
intake) and 
partially eaten 
under 
supervision
Veg only 4 NR
GP2 NR GP2 6.1
Plasma Fasted Yes
24
GP1 1.7 GP1 1.8
GP2 1.7 GP2 3.8
Wallace (33)
2013
High CVD 
risk
UK Parallel 105 56
Advice plus 
weekly home 
deliveries of F&V 
telephone call 
from researcher 
weekly
F&V 12 4
GP3 1.6 GP3 7.1
Plasma Fasted No
BMI, Body Mass Index; COPD, Chronic Obstructive pulmonary Disease; CVD, Cardiovascular disease; F&V, Fruit and vegetables; GP, Group; NR, Not reported
542
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Figure Legends543
Figure 1: PRISMA diagram of search results544
Figure 2: Summary of risk of bias among the 9 studies with 6 biomarkers measured.545
Figure 3: Funnel plots of 9 randomised controlled trials of different doses of fruit and 546
vegetable intake on biomarker concentrations547
Figure 4: Summary of pooled difference between arms consuming higher vs. lower 548
amounts of fruit and vegetables for standardised mean change (SMC) of biomarkers from 549
pre- to post-intervention in trials with all 6 biomarkers measured. SMC represents a 550
standard deviation of pre-intervention biomarker levels within each study. I2 is an indicator 551
of between-trial heterogeneity. Random effects meta-analysis was used to pool mean 552
differences. Includes the following studies for ALL biomarkers: Baldrick(26); Briviba(27); 553
Broekmans(28); Chong(29); Gill(23); McCall(30); Neville(31); Van Het Hof(32); Wallace(33). Total 554
number of trials is 9; total number of arms being compared is 22; total number of people 555
included is 667.556
Figure 5: Summary of pooled differences between arms consuming higher vs. lower 557
amounts of fruit and vegetables in standardised mean change (SMC) of biomarkers from 558
pre- to post-intervention in all trials with available data grouped by amount of fruit and 559
vegetables provided during the intervention. SMC represents a standard deviation of pre-560
intervention biomarker levels within each study. I2 is an indicator of between-trial 561
heterogeneity. Random effects meta-analysis was used to pool mean differences. P value 562
is from meta-regression test for trend across categories. Includes all studies up to n=19 563
based on availability of biomarker in each study.564





